Hartmut T.
- Country
- Germany
- Department
- N/A
Research Overview
- Efficacy and Safety of MET097 in Adults with Overweight or Obesity: A Phase 3, Randomized, Placebo-Controlled Trial
- Phase 3 Randomized, Placebo‑Controlled Trial Assessing Efficacy and Safety of MET097, a Long‑Acting GLP‑1 Receptor Agonist, in Overweight/Obese Adults with Type 2 Diabetes
- Evaluation of Oral Minoxidil 1 mg Efficacy and Safety in Female Androgenetic Alopecia: A Phase III Randomized, Double-Blind, Placebo-Controlled Trial
Data & Insights
Has run more than one trial at 269 of 877 partner sites.
Specializations
Respiratory Medicine
Specializes in preventive vaccination research targeting respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) in elderly populations. The investigator also focuses on advanced influenza vaccine development for adults with underlying health conditions.
- Viral respiratory infections in elderly
- Immunization strategies
- Vaccine immunogenicity assessment
Gastroenterology
Conducts research in the treatment of irritable bowel syndrome, with particular emphasis on diarrhea-predominant (IBS-D) and mixed-type (IBS-M) variants. The investigator evaluates therapeutic interventions for gastrointestinal disorders.
- Functional bowel disorders
- Gastrointestinal therapeutics
- Clinical symptom management
Cardiovascular and Women's Health
Investigates treatments for atherosclerotic cardiovascular disease and women's health conditions including primary dysmenorrhea and vasomotor symptoms in breast cancer patients. Additionally studies atrial fibrillation management approaches.
- Cardiovascular risk management
- Women's health therapeutics
- Anticoagulation therapy
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.